Results 141 to 150 of about 39,898 (187)

A case of childhood hyperekplexia due to a novel nonsense variant in the GLRA1 gene. [PDF]

Medicine (Baltimore)
Lin SZ, Sun XY, Tan YY, Qi YF, Jiang K.
europepmc   +1 more source

Gingival enlargement following levetiracetam treatment: A clinical case analysis. [PDF]

Epilepsia Open
Alahmari AM, Alkhathaami AM.
europepmc   +1 more source

Pregnancy, baby, and childhood outcomes from using anti-seizure medication during pregnancy. [PDF]

Commun Med (Lond)
Moore E, Millar M, Merrick R, Mueller T, Stark V, Jarvis L, Kurdi A, Hopkins L, McTaggart S, Vieira R, Bennie M, Wood R.   +11 more
europepmc   +1 more source

Levetiracetam-Aggravated Severe Treatment-Resistant Acne. [PDF]

Indian Dermatol Online J
Kothari R, Manoj R, Singh S, Gupta A.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Levetiracetam

Reactions Weekly, 2012
Levetiracetam (LEV) is a novel antiepileptic drug (AED) which was discovered in early 1980s and soon, in 1999 FDA approved LEV for the management of partial onset seizure. In India, LEV tablet was approved in April 2005. It acts by binding to the synaptic vesicle protein SV2A, which is present on synaptic vesicles and some neuroendocrine cells ...
Kavita, Krishna, Asawari L, Raut, Kushal H, Gohel, Priti, Dave   +3 more
  +5 more sources

Levetiracetam

CNS Drugs, 1997
[Symbol: see text] Levetiracetam is an ethyl analogue of the nootropic agent piracetam.[Symbol: see text] Results from rodent studies indicate that the drug may offer protection against absence, generalised and partial seizures.[Symbol: see text] Levetiracetam exhibits linear pharmacokinetics and has a wide therapeutic index.
M, Haria, J A, Balfour
openaire   +2 more sources